Richard Alan Vonder Embse

Title: Richard Alan Vonder Embse: Innovator in Pharmaceutical Chemistry

Introduction

Richard Alan Vonder Embse is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as inhibitors for various biological processes. With a total of two patents to his name, Vonder Embse continues to push the boundaries of innovation in his field.

Latest Patents

Vonder Embse's latest patents include the invention of pyrazole derivatives as 5-LO-inhibitors. This invention relates to compounds of a specific formula and outlines processes for their preparation, as well as their use as 5-lipoxygenase inhibitors and pharmaceutical compositions containing these compounds. Another significant patent involves processes for the preparation of a complex compound, specifically 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide. This invention is directed towards the preparation of compounds defined by a specific formula, showcasing Vonder Embse's expertise in chemical synthesis.

Career Highlights

Richard Alan Vonder Embse is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to pharmaceutical research and development.

Collaborations

Some of Vonder Embse's notable coworkers include Edgardo Alvira and Matthew James Graneto. Their collaborative efforts have likely played a role in advancing the innovative projects they have undertaken together.

Conclusion

Richard Alan Vonder Embse stands out as an influential inventor in the pharmaceutical sector, with a focus on developing innovative compounds that have the potential to impact health care significantly. His work at Pfizer and his patented inventions reflect his commitment to advancing medical science.